| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72a4a0bae6fe89685c930f3fb2fe1c6e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-08 |
| filingDate |
1988-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0340c6b3cc8992937b76e1821ba1c359
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9dd98b3a0a114182c5607cd6ac01b06a |
| publicationDate |
1989-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0321428-A2 |
| titleOfInvention |
Use of glycerol ethers in dermatological diseases |
| abstract |
This invention relates to the use of at least one glycerol ether as a means to affect diseases depending upon epidermal growth factor. The glycerol ethers are stable and can be orally administered in the form of capsules, which are brought on the market under the trademark ECOMER. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100918901-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1552827-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6380244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6624191-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2750333-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1552827-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7906557-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9958136-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9800120-A1 |
| priorityDate |
1987-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |